Timolol Maleate: Efficacy and Safety

Thom J. Zimmerman, Michael A. Kass, Michael E. Yablonski, Bernard Becker

Research output: Contribution to journalArticle

67 Scopus citations

Abstract

A randomized, double-masked trial of various concentrations of timolol maleate ophthalmic solution (0.1%, 0.25%, 0.5%, and 1.0%) vs placebo demonstrated that all concentrations of timolol effectively lowered intraocular pressure (IOP). A 0.5% solution of timolol was as effective in reducing IOP as the 1.0% concentration. Blood pressure, visual acuity, and pupillary diameter were not altered significantly by any concentration of timolol tested during this study. There was a dose-dependent decrease in resting pulse rate with increasing concentrations of timolol. No objective signs of drug intolerance were found on external ocular examination, nor were any subjective symptoms elicited on questioning the subjects. Timolol applied topically twice daily in concentrations of 0.1% to 0.5% appeared to be an effective and safe ocular hypotensive agent.

Original languageEnglish
Pages (from-to)656-658
Number of pages3
JournalArchives of Ophthalmology
Volume97
Issue number4
DOIs
StatePublished - Apr 1979

Fingerprint Dive into the research topics of 'Timolol Maleate: Efficacy and Safety'. Together they form a unique fingerprint.

  • Cite this